Table S1 from Purinostat Mesylate is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of ≪i>bcr-Abl</i>–induced B-Cell Acute Lymphoblastic Leukemia
openalex(2023)
关键词
HDAC Inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要